Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Hemantin inhibitor.
For use in amino acid analysis.
NSAID; COX-2 inhibitor.
TRPA1 agonist, xanthine oxidase inhibitor.
Negative control for PKC activation.
Phenol found in the creosote bush; 5-lipoxygena...
Imidazole; 14-α demethylase inhibitor, potenti...
Endogenous peptide hormone inolved in gastric e...
Tamoxifen derivative; potential proteasome inhi...
Imidazole; 14-α demethylase inhibitor.
Synthetic peptide; FPRL1 agonist.
Endogenous APP peptide cleavage product, primar...
Thienylbutyl ITC analog.
Thiazolidinedione; PPARγ agonist.
Nucleoside (deoxyguanosine) analog; DNA chain t...
AMPK activator.
PAK inhibitor.Smo inhibitor.
Polyphenol found in olive oil, antioxidant.
Phytoalexin, indole found in cruciferous vegeta...
Inhibitor of PTEFb/CDK9.